[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334025-105":59,"doc-detail-334025-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-complex-role-of-immune-cells-in-antigen-presentation-and-regulation-of-t-cell-responses-in-hepatocellular-carcinoma-progress-challenges-and-future-directions","The complex role of immune cells in antigen presentation and regulation of T-cell responses in hepatocellular carcinoma: progress, challenges, and future directions","","Hepatocellular carcinoma (HCC) presents substantial morbidity and mortality, with immune cell behavior playing a central role in antigen presentation and T-cell regulation. This review details how HCC balances immune surveillance and immune evasion, then examines the contributions of dendritic cells, natural killer cells, and CD8+ T cells to antigen presentation. It also analyzes how checkpoints, including CTLA-4 and PD-1/PD-L1, influence antigen presentation and the clinical relevance of checkpoint inhibitors. Finally, it highlights immune-based therapies such as cancer vaccines and CAR-T cells.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-complex-role-of-immune-cells-in-antigen-presentation-and-regulation-of-t-cell-responses-in-hepatocellular-carcinoma-progress-challenges-and-future-directions/334025/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-complex-role-of-immune-cells-in-antigen-presentation-and-regulation-of-t-cell-responses-in-hepatocellular-carcinoma-progress-challenges-and-future-directions/334025.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How do immune cells influence antigen presentation in hepatocellular carcinoma?","Question",{"text":113,"@type":114},"Immune cells, especially antigen-presenting cells such as dendritic cells and macrophages, capture tumor-specific antigens and deliver them to CD8+ cytotoxic T cells, initiating anti-tumor immune responses. The review emphasizes that mechanisms governing antigen presentation in HCC remain under active study.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which immune checkpoints are discussed regarding antigen presentation in HCC?",{"text":118,"@type":114},"The review discusses CTLA-4 and the PD-1/PD-L1 axis, explaining their impact on antigen presentation and their relevance to the performance of checkpoint inhibitors in HCC.",{"name":120,"@type":111,"acceptedAnswer":121},"What immune-based therapies does the review highlight for improving antigen presentation?",{"text":122,"@type":114},"It highlights immune-based therapies including cancer vaccines and CAR-T cell therapy, focusing on how they may enhance antigen presentation and improve future therapeutic directions.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334025,1790156689,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Review  \nPUBLISHED 22 October 2024  \nDOI 10.3389/fimmu.2024.1483834  \nOPEN ACCESS  \nEDITED BY  \nBing Yang,  \nTianjin Medical University, China  \nREVIEWED BY  \nJun Hu,  \nTianjin Medical University Cancer Institute and Hospital, China  \nShengshan Xu,  \nJiangmen Central Hospital, China Dong Wu,  \nZhuanghe Central Hospital, China  \n*CORRESPONDENCE  \nYutao Wang  \n [pumch_ytwang@126.com](pumch_ytwang@126.com)[ ](pumch_ytwang@126.com)Zijia Tao  \n [zjtao@cmu.edu.cn](zjtao@cmu.edu.cn)  \nRECEIVED 20 August 2024  \nACCEPTED 30 September 2024  \nPUBLISHED 22 October 2024  \nCITATION  \nNing J, Wang Y and Tao Z (2024) The complex role of immune cells in antigen presentation and regulation of T-cell responses in hepatocellular carcinoma:  \nprogress, challenges, and future directions. Front. Immunol. 15:1483834 .  \ndoi: 10.3389/fimmu.2024.1483834  \nCOPYRIGHT  \n© 2024 Ning, Wang and Tao. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe complex role of immune cells in antigen presentation and regulation of T-cell responses in hepatocellular carcinoma: progress, challenges, and future directions  \nJianbo Ning 1, Yutao Wang 2* and Zijia Tao 3*  \n1The Fourth Clinical College, China Medical University, Shenyang, China, 2 Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 3 Department of Interventional Radiology, the First Hospital of China Medical University, Shenyang, China  \nHepatocellular carcinoma (HCC) is a prevalent form of liver cancer that poses signiﬁcant challenges regarding morbidity and mortality rates. In the context of HCC, immune cells play a vital role, especially concerning the presentation of antigens. This review explores the intricate interactions among immune cells within HCC, focusing on their functions in antigen presentation and the modulation of T-cell responses. We begin by summarizing the strategies that HCC uses to escape immune recognition, emphasizing the delicate equilibrium between immune surveillance and evasion. Next, we investigate the speciﬁc functions of various types of immune cells, including dendritic cells, natural killer (NK) cells, and CD8+ T cells, in the process of antigen presentation. We also examine the impact of immune checkpoints, such as cytotoxic T-lymphocyteassociated protein 4 (CTLA-4) and the pathways involving programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1), on antigen presentation, while taking into account the clinical signiﬁcance of checkpoint inhibitors. The review further emphasizes the importance of immune-based therapies, including cancer vaccines and CAR-T cell therapy, in improving antigen presentation. In conclusion, we encapsulate the latest advancementsin research, propose future avenues for exploration, and stress the importance of innovative technologies and customized treatment strategies. By thoroughly analyzing the interactions of immune cells throughout the antigen presentation process in HCC, this review provides an up-to-date perspective on the ﬁeld, setting the stage for new therapeutic approaches.  \nKEYWORDS  \nhepatocellular carcinoma, dendritic cells, natural killer cells, CTLA-4, PD-1/PD-L1  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nHepatocellular carcinoma (HCC), the predominant type of liver cancer, poses a considerable challenge to global health, illustrated by rising incidence ﬁgures and concerning mortality rates (1–3). The complex relationships between cancerous cells and the host’s immune system are ","cbCaiejnig6lc2cn","https://ap.wps.com/l/cbCaiejnig6lc2cn","pdf",1017091,13,"English","# Introduction\n## Immune dysregulation and tumor immune evasion in HCC\n## Antigen presentation as a key checkpoint\n## Therapeutic implications of antigen presentation and checkpoints","[{\"question\":\"How do immune cells influence antigen presentation in hepatocellular carcinoma?\",\"answer\":\"Immune cells, especially antigen-presenting cells such as dendritic cells and macrophages, capture tumor-specific antigens and deliver them to CD8+ cytotoxic T cells, initiating anti-tumor immune responses. The review emphasizes that mechanisms governing antigen presentation in HCC remain under active study.\"},{\"question\":\"Which immune checkpoints are discussed regarding antigen presentation in HCC?\",\"answer\":\"The review discusses CTLA-4 and the PD-1/PD-L1 axis, explaining their impact on antigen presentation and their relevance to the performance of checkpoint inhibitors in HCC.\"},{\"question\":\"What immune-based therapies does the review highlight for improving antigen presentation?\",\"answer\":\"It highlights immune-based therapies including cancer vaccines and CAR-T cell therapy, focusing on how they may enhance antigen presentation and improve future therapeutic directions.\"}]","The complex role of immune cells in antigen presentation and regulation of T-cell responses in hepatocellular carcinoma: progress, challenges, and future directions | PDF",1790005052,33]